Associate Professor, Medicine, University of Wisconsin Medical School

Oncology

Dr. Daniel L. Mulkerin practices Oncology. He researched medicine at Jefferson Medical College. Daniel Mulkerin is also published. He has 10 publications published. The lastest publication: "A multicenter phase 1 study of -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.' Dr. Daniel L. Mulkerin accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid Tumors.
• A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced Cancer.
• Phase I Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study.
• A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract Cancer: a Wisconsin oncology network study.
• A preclinical and clinical study of lithium in low-grade neuroendocrine Tumors.
• A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal Cancer.
• Oxaliplatin pharmacokinetics and pharmacodynamics in adult Cancer patients with impaired renal function.
• Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid Tumors.
• Capecitabine-related neurotoxicity presenting as trismus.

Schools

---

• Thomas Jefferson University

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

Education

---

• University of Wisconsin
• Jefferson Medical College

Hospital

---

• University of Wisconsin Hospital and Clinics

Drug Facts

---

NPI NUMBER		1063473411
NPPES Provider LastName		MULKERIN
NPPES Provider FirstName		DANIEL
NPPES Provider ZIPCode		53792
NPPES Provider State		WI
Specialty Description		Medical Oncology
Total Claim Count		421.0
Distinct Opioid Count		3.0
Opioid Claim Count		66.0
Percent Opioid Claims		15.68

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1063473411
Last Name Of The Provider	MULKERIN
First Name Of The Provider	DANIEL
View All

Similar Doctors

---

	Dr. Shannon E. O'Mahar, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark E. Burkard, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael S. Huie, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark R. Albertini, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Charles H. Diggs, MD This Doctor is OpenDoctor Recommended.
	Dr. Glenn Liu, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jeremy P. Cetnar, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. George Wilding, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Douglas G. McNeel, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog